AI English summary of an SEC filing — figures as filed
Globe Life GLGlobe Life said net income for the 9 months ended September 30, 2024, 2023 was $816 million, up 17% from $696 million in the same period a year earlier. Diluted earnings per share rose from $7.20 to $8.93.
Key points
AI summaryGlobe Life said net income for the 9 months ended September 30, 2024, 2023 was $816 million, up 17% from $696 million in the same period a year earlier. Diluted earnings per share rose from $7.20 to $8.93.
The company said its life insurance underwriting margin for the 9 months rose to $1.02 billion in 2024 from $887 million in 2023. It also said it recorded a net remeasurement gain of $46.3 million from its annual assumptions review in Q3.
Globe Life said excess investment income for the 9 months rose 33% to $126 million from $95 million in the same period a year earlier. It also said it repurchased 9.7 million shares for a total of $910 million over the same period.
The company said it issued $450 million of 5.85% senior notes due September 15, 2034 on August 23, 2024, receiving net proceeds of $445 million, which it will use for general corporate purposes, including open market share repurchases. It also said its remaining borrowing capacity under its credit facility as of September 30, 2024 was $458 million.
Key figures
Quarter ended September 30, 2024
- Revenue
- $1.5B
- Operating income
- $383M
- Net income
- $303M
- EPS
- $3.44
- Gross profit
- $379M
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Globe Life 9-month net income $816 million, diluted EPS $8.93
Globe Life said net income for the 9 months ended September 30, 2024, 2023 was $816 million, up 17% from $696 million in the same period a year earlier. Diluted earnings per share rose from $7.20 to $8.93.
Source · Based on the MD&A text of the filing
Life insurance underwriting margin and Q3 assumptions review remeasurement gain
The company said its life insurance underwriting margin for the 9 months rose to $1.02 billion in 2024 from $887 million in 2023. It also said it recorded a net remeasurement gain of $46.3 million from its annual assumptions review in Q3.
Source · Based on the MD&A text of the filing
Excess investment income and share repurchases for 9 months
Globe Life said excess investment income for the 9 months rose 33% to $126 million from $95 million in the same period a year earlier. It also said it repurchased 9.7 million shares for a total of $910 million over the same period.
Source · Based on the MD&A text of the filing
Senior notes issuance and additional credit facility borrowing capacity
The company said it issued $450 million of 5.85% senior notes due September 15, 2034 on August 23, 2024, receiving net proceeds of $445 million, which it will use for general corporate purposes, including open market share repurchases. It also said its remaining borrowing capacity under its credit facility as of September 30, 2024 was $458 million.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…